“…Nonetheless, MSCs offer tissue engineering a means to fully evaluate biomaterial interactions and afford a cell line capable of undergoing osteogenesis. Typical characterization of mesenchymal stem cells consists of their expression of specific protein markers such as, but not limited to, CD44, CD71, CD90, CD105, CD106, and CD166 (40,52,53), and the ability of the MSCs to differentiate down osteogenic (41,48,(54)(55)(56)(57)(58)(59)(60)(61)(62), adipogenic (41,48,63,64), chondrogenic (3,41,48,(65)(66)(67)(68), fibrogenic (69-71) myogenic (48,57,72), and neuronal (41,46,57,73) lineages. The majority of applications using stem cells for tissue or organ replacement typically use bone marrow-derived mesenchymal stem cells (BMMSCs) (55,66,(70)(71)(72)(74)(75)(76).…”